Quick Answer
Sarepta Therapeutics, Inc. reported Common Stock Shares Outstanding of 104.96 million shares for the year ending 2025.
- Sarepta Therapeutics, Inc. showed an increase of +8.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Sarepta Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 135.69 million shares | Q3 2011: 135.73 million shares | Q1 2012: 135.74 million shares | Q2 2012: 22.62 million shares | Q3 2012: 24.30 million shares | Q1 2013: 31.89 million shares | Q2 2013: 32.43 million shares | Q3 2013: 37.53 million shares | Q1 2014: 37.99 million shares | Q2 2014: 40.80 million shares | Q3 2014: 41.30 million shares | Q1 2015: 41.35 million shares | Q2 2015: 41.52 million shares | Q3 2015: 41.96 million shares | Q1 2016: 45.77 million shares | Q2 2016: 47.87 million shares | Q3 2016: 54.35 million shares | Q1 2017: 54.94 million shares | Q2 2017: 55.34 million shares | Q3 2017: 64.57 million shares | Q1 2018: 65.49 million shares | Q2 2018: 66.35 million shares | Q3 2018: 66.69 million shares | Q1 2019: 74.13 million shares | Q2 2019: 74.33 million shares | Q3 2019: 74.50 million shares | Q1 2020: 77.96 million shares | Q2 2020: 78.43 million shares | Q3 2020: 78.79 million shares | Q1 2021: 79.75 million shares | Q2 2021: 79.83 million shares | Q3 2021: 79.96 million shares | Q1 2022: 87.50 million shares | Q2 2022: 87.54 million shares | Q3 2022: 87.77 million shares | Q1 2023: 93.14 million shares | Q2 2023: 93.27 million shares | Q3 2023: 93.54 million shares | Q1 2024: 94.49 million shares | Q2 2024: 95.28 million shares | Q3 2024: 95.49 million shares | Q1 2025: 98.25 million shares | Q2 2025: 97.71 million shares | Q3 2025: 104.77 million shares.
- Over the full 16 years of available data (2010 to 2025), Sarepta Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 6.6%.
- Historical annual values: Fiscal year 2025: 104.96 million shares | Fiscal year 2024: 96.90 million shares | Fiscal year 2023: 93.73 million shares | Fiscal year 2022: 87.95 million shares | Fiscal year 2021: 87.13 million shares | Fiscal year 2020: 79.37 million shares | Fiscal year 2019: 75.18 million shares | Fiscal year 2018: 71.07 million shares | Fiscal year 2017: 64.79 million shares | Fiscal year 2016: 54.76 million shares | Fiscal year 2015: 45.63 million shares | Fiscal year 2014: 41.31 million shares | Fiscal year 2013: 37.75 million shares | Fiscal year 2012: 31.70 million shares | Fiscal year 2011: 22.62 million shares | Fiscal year 2010: 112.35 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: